68
34
Growth Score
-14 pts
Heat Score
-19 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
735227
MC2 Therapeutics is a privately held emerging pharmaceutical company.
- Lars Iversen: Chief Medical Officer
- Trine Ahlgreen: Chief Executive OfficerPast Role: Micreos, Chief Business Officer
About the Company
MC2 Therapeutics drives innovation and program development from a lean core organization in close collaboration with a network of highly specialized, fully integrated and contributing experts and service providers. In addition to our core team, MC2 Therapeutics employs a large number of retained external contributors and consultants enabling us to
bring further expertise to our work.
